Flavonoids: Hemorheological effects and mechanisms of action
Naunyn-Schmiedeberg's Archives of Pharmacology · 15.08.2026
DOI: 10.1007/s00210-026-05763-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 15.08.2026. Verfasst von Anna M Anishchenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Ac…. Die Arbeit nennt 202 Literaturangaben.
Abstract (Originalsprache)
Flavonoids exhibit a wide range of biological activities, including antioxidant, anti-inflammatory, antidiabetic, antitumor, antiproliferative, and hemorheological effects. This review discusses the hemorheological activity of flavonoids and the underlying mechanisms. The hemorheological activity of flavonoids and flavonoid complexes has been studied in both in vitro and in vivo models of myocardial infarction, arterial hypertension, atherosclerosis, cerebrovascular insufficiency, pancreatitis, hepatitis, and rheumatoid arthritis, as well as in aging animals. Flavonoids are known to decrease whole blood viscosity, reduce red blood cell (RBC) aggregation, improve RBC deformability, and even, in some cases, decrease fibrinogen levels and plasma viscosity. The key mechanisms underlying the hemorheological effects of flavonoids are the following: (1) antioxidant protection from oxidative stress and (2) stabilization of membrane fluidity. The antioxidant effect is mediated through neutralization of reactive oxygen species outside RBCs, within the RBC membrane, and in the cytoplasm, thereby protecting RBC membranes (both lipid and protein constituents) from oxidative damage. Flavonoids also contribute to the maintenance and enhancement of endogenous antioxidant defense systems in RBCs. Clinical trials of flavonoid-based agents have demonstrated both hemorheological activity and therapeutic efficacy in patients with diabetes mellitus, coronary heart disease, venous insufficiency, dyscirculatory encephalopathy, arterial hypertension, and other conditions. The introduction of effective and low-toxicity flavonoid preparations with hemorheological activity into treatment regimens for conditions associated with hyperviscosity syndrome may enable the development of new therapeutic strategies for many diseases and improve patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
- Department of Pharmacology, Siberian State Medical University, Tomsk, Russia.
- Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. plotnikovmb@tnimc.ru.
- Faculty of Radiophysics, National Research Tomsk State University, Tomsk, Russia. plotnikovmb@tnimc.ru.
Zitieren
APA
Anishchenko, A. M., Aliev, O. I., & Plotnikov, M. B. (2026). Flavonoids: Hemorheological effects and mechanisms of action. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05763-2
Vancouver
Anishchenko AM, Aliev OI, Plotnikov MB. Flavonoids: Hemorheological effects and mechanisms of action. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05763-2
BibTeX
@article{Anishchenko2026,
author = {Anishchenko, Anna M and Aliev, Oleg I and Plotnikov, Mark B},
title = {Flavonoids: Hemorheological effects and mechanisms of action},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05763-2}
}
EUVIMED